post-transplant lymphoproliferative disease
Findings
No curated finding names post-transplant lymphoproliferative disease yet. Everything below is reference data from Mondo, HPO and GenCC, not evidence about what affects it.
Definition
Post-transplant lymphoproliferative disorder (PTLD) is a polyclonal (benign) or clonal (malignant) proliferation of lymphoid cells that develops as a consequence of immunosuppression in a recipient of a solid organ or bone marrow allograft. PTLDs comprise a spectrum ranging from early, Epstein-Barr virus (EBV)-driven polyclonal lymphoid proliferations to EBV-positive or EBV- negative lymphomas of predominantly B-cell or less often T-cell type. (WHO, 2001)
Definition from the Mondo Disease Ontology (MONDO:0019088), read 2026-09-29. CC BY 4.0.
Features
16 features
What the disease is reported to present with, and how often among people who have it — never how often a feature means the disease. HPO, annotations 2026-09-02.
- Abnormality of the voiceHPOHP:0001608
- Frequent (30% to 79% of cases)
- FatigueHPOHP:0012378
- Frequent (30% to 79% of cases)
- FeverHPOHP:0001945
- Frequent (30% to 79% of cases)
- LymphadenopathyHPOHP:0002716
- Frequent (30% to 79% of cases)
- MalaiseHPOHP:0033834
- Frequent (30% to 79% of cases)
- Night sweatsHPOHP:0030166
- Frequent (30% to 79% of cases)
- PharyngalgiaHPOHP:0033050
Show the remaining 4
- Gastrointestinal hemorrhageHPOHP:0002239
- Occasional (5% to 29% of cases)
- HepatitisHPOHP:0012115
- Occasional (5% to 29% of cases)
- HypoalbuminemiaHPOHP:0003073
- Occasional (5% to 29% of cases)
- Pulmonary noduleHPOHP:0033608
- Occasional (5% to 29% of cases)
Where it sits
- A kind of
Other names
2 names
Resolves to: post-transplant lymphoproliferative disease
- Also called
- post-transplant lymphoproliferative disorderPTLD